参附注射液治疗高龄急性前壁心肌梗死伴多种并发症中西医结合诊治举隅  

Clinical application of Shenfu Injection in treating with acute anterior myocardial infarction associated with complications in aged patients

作　　者：谢培怡[1] 

机构地区：[1]浙江省立同德医院心内科,杭州310012

出　　处：《中华中医药杂志》2014年第10期3155-3157,共3页China Journal of Traditional Chinese Medicine and Pharmacy

摘　　要：高龄女性患者,以急性胸痛6h入院,诊断急性前壁心肌梗死,既不适宜溶栓亦不同意作冠脉介入治疗。在西医规范治疗的基础上出现心梗后心绞痛,房室传导阻滞,心力衰竭,心源性休克。停用多巴胺、β-阻滞剂、以及扩血管药。中医辨证系真心痛,阳气暴脱,阴寒血滞型。选用参附注射液50mL静脉滴注,治疗2周后,症状消失,抢救成功,步行出院。参附注射液对急性冠脉综合症中出现的心梗后心绞痛,房室传导阻滞,心力衰竭,心源性休克非常实用有效。Shenfu Injection was observed in rescuing the angina pectoris patient with syndrome of sudden collapse of heart yang, and syndrome of concretion of severe pathogenic cold. An aged female patient was admitted to hospital with 6 hours＇ acute chest pain and diagnosed of acute anterior myocardial infarction. The patient neither was suitable for thrombolysis nor agreed with coronary interventional treatment. On the basis of the standard treatment of western medicine, angina after myocardial infarction, atrioventricular block, heart failure and cardiogenic shock appeared, so it was necessary to stop the application of dopamine, B blockers and vasodilators. TCM diagnosis of the patient was described as angina pectoris with syndrome of sudden collapse of heart yang, and syndrome of concretion of severe pathogenic cold. The patient was treated with Shenfu Injection 50mL every day. After treatment for 2 weeks, the symptoms disappeared, and the patient was rescued successfully. Shenfu Injection is effective in treating with acute coronary syndrome （ACS） after myocardial infarction such as angina pectoris, atrioventricular block, heart failure and cardiogenic shock.

关 键 词：急性心肌梗死 参附注射液 老年患者 高龄 

分 类 号：R249[医药卫生—中医临床基础] R259[医药卫生—中医学]